HOME >> MEDICINE >> NEWS
Fatty liver a possible risk for hypertension, cardiovascular disease

were taken at baseline, including GGT, blood pressure, weight, abdominal height and size of waistline.

At the six-year follow-up, participants were divided into five groups according to their baseline GGT levels. The baseline measurements were repeated, and participants completed questionnaires concerning lifestyle and health habits, including alcohol use.

Fatty liver has no symptoms, but it can develop into the chronic conditions of hepatitis or cirrhosis.

Stranges said these findings suggest that fatty liver should be considered part of the metabolic syndrome, a cluster of conditions physicians use to help assess a patient's risk for cardiovascular disease.

Persons with any three of the conditions are considered at high risk. Conditions currently included in the metabolic syndrome are abdominal obesity, low HDL cholesterol, high blood sugar, high blood pressure and high triglycerides.

Stranges and colleagues are now studying the association between liver enzymes and diabetes.


'"/>

Contact: Lois Baker
ljbaker@buffalo.edu
716-645-5000 x1417
University at Buffalo
2-Nov-2005


Page: 1 2

Related medicine news :

1. Fatty fish protects against cancer
2. Fatty fish consumption associated with lower risk of kidney cancer in women
3. Fatty diet does not increase risk of skin cancer
4. Fatty foods fight inflammation
5. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
6. When HIV and liver disease co-exist
7. New Mayo Clinic MRI technology enables noninvasive liver diagnoses
8. Why Lincoln fell gravely ill after delivering his Gettysburg Address
9. Smokeless cannabis delivery device efficient and less toxic
10. HCV patients survival after liver transplantation is not improving
11. Revolutionizing prosthetics 2009 team delivers first DARPA limb prototype

Post Your Comments:
(Date:3/3/2015)... March 03, 2015 The combinatorial, ... predict antidepressant treatment outcomes for patients with depression, ... any of the individual genes that comprise the ... from the Mayo Clinic and Assurex Health, and ... , The proprietary technology of the GeneSight Psychotropic ...
(Date:3/3/2015)... The Calistoga Chamber of Commerce announces a brand new ... Friday, March 27, through Sunday, March 29, 2015. The weekend-long ... restaurant and bar crawl, lodging and spa specials, yoga and ... and older. , A variety of lodging and spa properties ... by offering Mudder of All Weekends packages featuring special room ...
(Date:3/3/2015)... March 03, 2015 Introducing 3D ... Labs is a recognized leader in Digital Dentistry. ... produces the best dental replicas, leaving no room ... digital scanning, dental professionals are able to significantly ... printers consistently deliver remarkable quality while reducing labor ...
(Date:3/3/2015)... CA (PRWEB) March 03, 2015 ... and collaboration, announces Mirroring360 is now available for Epson® ... download from the Moverio Apps Market , iPod, ... mobile device experience to the Epson Moverio smart glasses ... usage models. , The Epson smart glasses ...
(Date:3/3/2015)... Retrofit , the comprehensive weight ... corporations, today announces the appointment of its new chief ... Mary Pigatti has recruited technology, healthcare and ... for the fast-growing company, which was recently named one ... 2015. , “Retrofit is thrilled to announce this new ...
Breaking Medicine News(10 mins):Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 2Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 4Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 6Health News:Visit Calistoga Hosts Mudder of All Weekends Girlfriend Getaway Event 2Health News:Visit Calistoga Hosts Mudder of All Weekends Girlfriend Getaway Event 3Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 2Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 3Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 2Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 3Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 2Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 3Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 4
(Date:3/3/2015)... COLORADO SPRINGS, Colo. , March 3, 2015 /PRNewswire/ ... in the development of cannabis-based medicine, today announced two ... preparation for its multiple global product launches, and CEO ... views in the Chicago HR Examiner. In ... C. Waits about leading a company in an ...
(Date:3/3/2015)... Mar. 03, 2015 Research and Markets ... PharmaBiotech,s new report "Cardiovascular Drug Delivery - Technologies, ... Drug delivery to the cardiovascular system is ... anatomy and physiology of the vascular system; it supplies ... Drugs can be introduced into the vascular system for ...
(Date:3/3/2015)... YORK , March 3, 2015  Delcath ... specialty pharmaceutical and medical device company focused on ... primary and metastatic liver cancers, announces that the ... completed enrollment in 2009, have been submitted for ... clinical study utilized Melphalan Hydrochloride for Injection for ...
Breaking Medicine Technology:CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 2CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 3CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 4CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 5Global Cardiovascular Drug Delivery Technologies, Markets and Companies 2014-2024 2Global Cardiovascular Drug Delivery Technologies, Markets and Companies 2014-2024 3Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 2Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 3Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 4
Cached News: